Nice reference... Monsanto with the 60B market cap... i think i could live with that outcome... wouldn't that be something... interesting comparable...
One of the things i most like about xxii is what a mature company it has become, and so very quickly... it is not one thing... not simply tobacco... not simply biopharm... not simply product... not simply licensing... not simply manufacturing... it is all of those things, but not simply anyone of them... there is tremendous mitigation of risk in a company like this... and one with virtually no debt... and ready for an uplist... all at the same time...
tobacco, biopharm, product, licensing, manufacturing... any one of these if successful would likely sustain the current low market cap... so for investors to lose money on this entry point or lower... it would truly have to be an epic fail... throw on top of this a management that delivers on its promises... over and over again... and on time... and this is simply a very unique investment opportunity... Van and his team did a great job in sniffing this one out and letting us know about it...
Love Monsanto as a comparable... that would yield a split adjusted pps sometime into the future of something like $1,200 pps... ok now stop that... see what you made me do :-)
Market Data 
Markets 
AI
